Immunotherapy and DNA damage repair combo could target lung cancer
Combination therapy with a CHK1 or PARP inhibitor, with an immune checkpoint inhibitor caused the regression of small cell lung cancer in all mice treated...
List view / Grid view
Genomics is the branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes.
Combination therapy with a CHK1 or PARP inhibitor, with an immune checkpoint inhibitor caused the regression of small cell lung cancer in all mice treated...
A method has been developed to reprogram stem cells using the measles virus vector, cutting a four-step process to only one stage...
An assay assessing the level of programmed death ligand 1 (PD-L1) could help to determine the method of treatment for lung cancer patients...
Researchers have suggested that the most widespread human malaria parasite could be studied and possibly treated using genomics...
Using transcription factors to explore and understand the genome could lead to the understanding of gene expression patterns...
Scientists discover new genes and biological pathways linked to osteoarthritis, which could help identify starting points for new medicines...
Researchers have identified how they can differentiate between lesions in the airways that are benign and those that could become cancerous...
Mobile-CRISPRi could be used to guide gene expression, in turn control levels of proteins produced, enabling scientists to identify key antibiotic targets...
A stem cell therapy rectifying the FoxP3 gene has been developed to treat IPEX, and has virtually cleared symptoms of the condition in mice...
Learn everything you need to know about the most widely-used mouse in biomedical research with this free whitepaper.
A study has given insight into gene expression and could enable scientists to determine how certain RNAP inhibitors work within the body...
Learn how the continued development of CRISPR gene editing technologies opens fresh possibilities for in vivo model design.
The catastrophic consequences of ever-increasing rates of death from infectious diseases demands new experimental strategies for drug target selection and drug design. Over the last decade, the pharmaceutical industry has been wounded by several issues including failure of drug-development programmes, burgeoning cost of drug development, increasing regulatory control, lack of…
The basic premise of drug discovery screening necessitates that the biological assays upon which it depends can be performed in a reproducible manner. In addition, the techniques employed must generate results that are biologically relevant and actionable.
Frizzled receptors, from the GPCR family, could soon be a target to treat numerous diseases such as cancer, fibrosis and CVD...